** Genpact G.N up 11.6% to $55.13 after hitting record high of $56.76 and on track for biggest daily pct gain since Aug 9
** The professional services company reported Q4 adj EPS and revenue that topped Street estimates after the close on Thursday while also giving its Q1 and FY 2025 outlook
** BMO raised its price target on the stock to $58 from $53 but kept its "market perform" rating intact, noting the FY2025 guidance "appears prudent" but the firm said it still questions the durability of growth longer term.
** Jefferies equity analyst Surinder Third reiterated "buy" rating, said, "Many of the strategic changes implemented earlier in the year appear to have coalesced, which leads us to believe growth has the potential to show further improvement in 2025."
** Needham raised its price target on the stock to $65 from $55 per share
** Of 11 analysts covering Genpact Ltd, breakdown of recommendations are 5 "strong buy" or "buy" and 6 "hold" ratings
** Median price target of $57 is up from $48 a month ago and from $41 on Nov 7
(Reporting by Chuck Mikolajczak)
((charles.mikolajczak@tr.com; @ChuckMik;))
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。